NIDDK

1 stories · following the connections

Business

Crinetics Pharmaceuticals Awarded $2.8 Million SBIR Grant to Support Development of Acromegaly Drug Candidate CRN00808

By Nasdaq OMXJul 13, 2017, 5:00 PM UTC